angiotensin ii, des-phe(8)- has been researched along with osteoprotegerin in 1 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (osteoprotegerin) | Trials (osteoprotegerin) | Recent Studies (post-2010) (osteoprotegerin) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 5,108 | 212 | 2,726 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuohashish, HM; Ahmed, MM; Al-Rejaie, SS; Khattab, MM; Sabry, D | 1 |
1 other study(ies) available for angiotensin ii, des-phe(8)- and osteoprotegerin
| Article | Year |
|---|---|
Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas receptor axis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blotting, Western; Female; Humans; Organ Size; Osteoporosis; Osteoprotegerin; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; RANK Ligand; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Uterus | 2017 |